Whole-body MRI provides a broad overview of many tissues, but a result may still require dedicated imaging, another modality or pathology.
What the radiologist reviews
The radiologist assesses anatomical MRI sequences and diffusion-weighted images across the regions included in the protocol. The most recent previous imaging is compared for oncology staging or if clinically relevant when available. The report describes important findings, limitations and any recommended next step.
Where whole-body MRI is often strong
- Bone marrow and skeletal abnormalities.
- Many soft-tissue masses and organ lesions.
- Lymph nodes and disease distribution across multiple regions.
- Selected cancer staging, surveillance and treatment-response assessment.
- Incidental musculoskeletal, spinal and organ findings within the scan coverage.
Important limitations
Whole-body MRI is not equally sensitive for every organ or disease. Very small lung nodules are generally better assessed with CT. Superficial skin lesions and many mucosal abnormalities may not be visible. Motion can reduce detail in the chest and abdomen.
Dedicated MRI uses smaller fields of view and specialised sequences that may show more detail than a whole-body protocol for specific clinical questions. A broad scan cannot replace every organ-specific examination.
Why another test may be recommended
Pathology is variable and often requires multimodality assessment for confident diagnosis. A finding may be better characterised with ultrasound, Spectral CT, dedicated MRI, PET/CT, mammography, endoscopy, blood testing or biopsy.
A recommendation for additional imaging does not automatically mean cancer. It means the broad examination has identified something that requires a more targeted answer.
Incidental findings
Whole-body MRI can reveal unexpected findings unrelated to the original reason for the scan – for asymptomatic patients one could argue that no findings are incidental when you are looking for everything. Many findings are benign and require no action. Others may need comparison, surveillance or a dedicated examination. Your referring clinician should review the report in the context of your personal risk and history. MBR Health will characterise all lesions to Onco-RADs grading.
What a normal result means
A normal whole-body MRI is reassuring within the limits of the protocol. It does not guarantee the absence of microscopic disease, all early cancers or abnormalities outside the scan coverage. Continue recommended national and organ-specific screening.
Related Patient Guides
- PG1008 Whole-Body MRI Preparation Guide
- PG1010 Prostate MRI: How to Prepare and What to Expect
- PG1011 Breast MRI: How to Prepare and What to Expect
- PG1012 Liver, Pancreas and Abdominal MRI: Preparation, Contrast and MRCP
- PG1013 MR Neurography: Imaging Nerves More Clearly
- PG1014 Spine MRI: Discs, Nerves, Facet Joints and the Spinal Canal
- PG1015 Musculoskeletal MRI: Tendons, Ligaments, Cartilage and Bone Marrow
We have more information on Why Not All Whole Body MRIs are the Same and other more detailed information on our Insights page
Frequently Asked Questions
For other FAQs please visit our FAQs page
Why does my report mention “clinical correlation”?
Imaging findings sometimes need to be interpreted with symptoms, examination findings, blood tests or other clinical information.
Why was a dedicated scan recommended after a whole-body MRI?
A dedicated scan can use thinner slices, targeted contrast timing or specialised sequences to answer a specific question.
Can the report diagnose the exact type of tumour?
Sometimes imaging strongly suggests a diagnosis, but tissue sampling may still be required to identify the exact pathology.
| Important: Review the report with your referring clinician and complete any recommended follow-up within the advised timeframe. |
PATIENT GUIDE • PG-1009 [Patient information: Whole-body MRI provides a broad overview of many tissues, but a result may still require dedicated imaging, another modality or pathology.]
